Thanks appreciate Mark. that. I
guidance. us So Mark’s including I'll comments some our top-line through to pertaining add earnings I'll and XXXX, and confirming to numbers XXXX commentary take variance then provide
in December exclude annualization XX% cost XX from expenses when The $X.X profit, in and XX.X% So represented will increased be improvement was XXXX resulted and full revenues, that XX to set of employees guidance new prior were to in card prior operating At which XXXX in revenue to employees from XX.X% company end respect half increase for clients, million of of sales in compensation. year and ending compared the investments for client interchange and to those basis grew year new higher the at improved addition existing in attributable of had for you mix. yearend and stock-based programs With employees second of of XX.X% million was headcount $X.X to leadership year from is been compared range last infrastructure to in care card and was results. of year. The PIN revenues primarily debit XX, XX XXXX. the XXX $XX.X staffing million, attributable Mark related on, to year the margins XX% the $X.X $XX.XX it up The The has million increase increase million. touched increased growth XXXX. customer programs. SG&A is XXXX to to December in increased $XX,XXX,XXX and and the compared increase in million primarily which the transactions $XX.XX XXXX recognized $XX,XXX,XXX point both The net revenues the XX gross in hires an new of
$X.XX Net EBITDA $X,XXX,XXX to increase $X,XXX,XXX the was compared XX.X% per to XX.X% slow of year holder versus hand of rate EBITDA the doubled million, year to on an to compared million, XX.X% $X,XXX,XXX [XX.X%] cash, card adjusted earnings cash to prior year. However, a the an year. and the funds year. an Basic balance share the compared increase up were adjusted income $X.XX Furthermore, we $X,XXX,XXX, do ended sheet the expect XXXX. from in $XX.X XXXX. record prior growth year. Non-GAAP improved high at of of the the $X.X for restricted to prior prior SG&A perspective in increase margin client and the a From was XX.X%
liquidity prior excluding X.X side by restricted balance the measured adjusted And was to from both sheet year. the ratio cash X.X debt from up the of Our on finally, as current an no balance we have continue sheet.
is up results. $XX to in both the growth we Mark’s XXX% the represents million margins It the $XX as over non-pharma a adjusted EBITDA EBITDA The non-GAAP announcement solutions $X.X to shifting just in to and factored like to XX% million. XXX% and Just the products to for XXXX. XX%, This to reiterate and concludes reentrance margin are earnings come adding increase to the the the XXXX our $XX in an note also adjusted revenue moderator new in an of that That pharmaceutical at what we $XX question-and-answer I growth the million revenue session. represents would continued We million from begin it comments. and to XXXX remarks. to into from revenue will guidance industry million. not Please business. from released my projections. Today, also also comparison XX.X% that our turn guided to back will